Published: Guidance, quality standards and advice
Showing 1211 to 1220 of 2419
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Drug misuse prevention | QS165 | ||
| Trauma | QS166 | ||
| Eribulin for treating locally advanced or metastatic breast cancer after 1 chemotherapy regimen | TA515 | ||
| Cabozantinib for treating medullary thyroid cancer | TA516 | ||
| Learning disabilities and behaviour that challenges: service design and delivery | NG93 | ||
| Emergency and acute medical care in over 16s: service delivery and organisation | NG94 | ||
| Physical activity and the environment | NG90 | ||
| Brodalumab for treating moderate to severe plaque psoriasis | TA511 | ||
| Tivozanib for treating advanced renal cell carcinoma | TA512 | ||
| Obinutuzumab for untreated advanced follicular lymphoma | TA513 |